Investor Relations
Information and resources for current and prospective investors
Investment Opportunity
Daktari Biotechnology represents a unique investment opportunity in the growing African biotechnology sector. Our focus on innovative solutions for healthcare challenges positions us for sustainable growth and impact.
Market Leadership
Positioned as a leader in biotechnology innovation in Africa, with expanding global reach.
Sustainable Growth
Consistent revenue growth driven by diversified product portfolio and strategic partnerships.
Strong Financials
Robust financial performance with strategic reinvestment in research and development.
Innovation Pipeline
Robust pipeline of innovative products addressing critical healthcare needs.
Financial Highlights
Annual Revenue
$24.5M
+18% YoY
R&D Investment
$8.2M
+22% YoY
Market Valuation
$120M
+15% YoY
Investment Strategy
Our investment strategy focuses on sustainable growth through strategic expansion of our product portfolio, research capabilities, and market reach. We prioritize:
Research and development of innovative healthcare solutions
Expansion of manufacturing capabilities and capacity
Strategic partnerships to enhance market access
Talent acquisition and development
Digital transformation and technological advancement
Investor Resources
Annual Report 2023
Comprehensive overview of our financial performance and strategic initiatives.
Quarterly Results Q1 2024
Latest financial results and business updates.
Investor Presentation
Detailed presentation on our business model, growth strategy, and market opportunity.
Corporate Governance
Information on our governance structure, board of directors, and policies.
Investor Contact
For investor relations inquiries, please contact our team:
Email: investors@daktaribiotech.com
Phone: +254 (0) 123 456 789